文献速递免疫规划传染病防控与疫情报告

接种一剂麻腮风疫苗的3-7岁儿童免疫衰减与潜在无症状感染的4年前瞻性研究

Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: A 4-year prospective study.
PubMed 文献 · Vaccine · 2021-05-13

本研究对3346名仅接种一剂麻腮风疫苗(MMR)的3-7岁儿童进行4年前瞻性观察,发现腮腺炎IgG抗体血清阳性率从2015年的79.6%降至2018年的71.4%,且部分儿童出现血清转阴和无症状感染,提示一剂MMR免疫衰减与无症状感染共存,应优先确定第二剂MMR的最佳接种年龄。

要点

  • 仅接种一剂MMR的3-7岁儿童腮腺炎抗体阳性率随年份下降,2018年降至71.4%。
  • 约11.1-15.9%的儿童在随访中由血清阳性转为阴性,存在免疫衰减。
  • 6.1-9.9%的儿童发生无症状感染,提示隐性传播可能。

核心结论

  • 仅接种一剂MMR的幼儿园和小学儿童患腮腺炎风险较高,免疫衰减、血清转阴和无症状感染共存。
  • 应优先确定儿童第二剂MMR的最佳接种年龄,以改善中国腮腺炎防控。

研究设计与样本

  • 观察性前瞻性研究,纳入2015、2016和2018年采集血样的3-7岁儿童,共3346名完成三轮采血。
  • 分析腮腺炎IgG抗体血清阳性率和几何平均浓度随时间的变化。

主要发现

  • 2015年总体血清阳性率为79.6%,显著高于2016年的73.1%和2018年的71.4%。
  • 2015年至2016年,约11.6-15.9%的参与者由血清阳性转为阴性;2016年至2018年,11.1-14.6%的参与者由血清阳性转为阴性。
  • 2015年至2016年,超过6.1-7.4%的参与者发生无症状感染;2016年至2018年,9.0-9.9%的参与者感染但无临床症状。

临床怎么用

  • 对仅接种一剂MMR的3-7岁儿童,应关注腮腺炎免疫衰减和血清转阴,考虑适时接种第二剂。
  • 无症状感染的存在提示需加强幼儿园和小学的腮腺炎监测与防控。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mumps outbreaks in adolescents who received two doses of measles-mumps-rubella vaccine (MMR) during childhood have been reported worldwide. In China, one dose of MMR administered in children aged among 18-24 months has a limited effect on the mumps epidemic. There are limited prospective studies evaluating the mumps immunity profile of children aged 3-7 years who received one dose of MMR. This study aimed to describe mumps immunity profile over a span of 4-years in kindergarten and primary school children. METHODS: An observational, prospective study on one-dose MMR in children aged 3-7 years who underwent blood sample collection in 2015, 2016, and 2018 was conducted from 2015 to 2018. The seropositivity and geometric mean concentration of mumps IgG antibodies over time were analyzed. RESULTS: A total of 3346 eligible children aged 3-7 years who underwent three rounds of blood sample collection were included. The overall seropositivity (79.6%) in 2015 was significantly higher than those recorded in 2016 (73.1%) and 2018 (71.4%). Approximately 11.6-15.9% of the participants were seropositive for mumps in 2015, and converted to negative in 2016. Meanwhile, 11.1-14.6% of the participants were seropositive for mumps in 2016, and the results converted to negative in 2018. Over 6.1-7.4% of the participants had asymptomatic infection from 2015 to 2016, while 9.0-9.9% of the participants were infected without clinical symptoms from 2016 to 2018. CONCLUSIONS: Kindergarten and primary school children who only received one dose of MMR were at higher risk of developing mumps. Waning immunity, seronegative conversion, and asymptomatic infection coexist in children who received one dose MMR. Determining the optimal age for administering the second dose of MMR in children should be prioritized to improve the control and prevention of mumps in China.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liu Y, Xiong Y, Liang Y, et al. Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: A 4-year prospective study. Vaccine. 2021. PMID: 33994238. doi:10.1016/j.vaccine.2021.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。